Soligenix Inc (SNGX)
0.3926
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
0.3924
0.00 (0.00%)
After-Hours: 20:00
Soligenix Accounts Payable (Quarterly): 1.437M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.437M |
December 31, 2023 | 1.111M |
September 30, 2023 | 1.461M |
June 30, 2023 | 2.472M |
March 31, 2023 | 2.769M |
December 31, 2022 | 3.866M |
September 30, 2022 | 4.165M |
June 30, 2022 | 4.141M |
March 31, 2022 | 4.518M |
December 31, 2021 | 2.926M |
September 30, 2021 | 1.906M |
June 30, 2021 | 1.482M |
March 31, 2021 | 1.340M |
December 31, 2020 | 2.130M |
September 30, 2020 | 2.445M |
June 30, 2020 | 2.522M |
March 31, 2020 | 2.871M |
December 31, 2019 | 2.735M |
September 30, 2019 | 2.258M |
June 30, 2019 | 2.452M |
March 31, 2019 | 1.583M |
December 31, 2018 | 2.126M |
September 30, 2018 | 1.714M |
June 30, 2018 | 1.686M |
March 31, 2018 | 1.754M |
Date | Value |
---|---|
December 31, 2017 | 1.754M |
September 30, 2017 | 1.478M |
June 30, 2017 | 1.611M |
March 31, 2017 | 1.347M |
December 31, 2016 | 1.708M |
September 30, 2016 | 3.120M |
June 30, 2016 | 4.177M |
March 31, 2016 | 4.633M |
December 31, 2015 | 2.869M |
September 30, 2015 | 4.347M |
June 30, 2015 | 2.636M |
March 31, 2015 | 2.544M |
December 31, 2014 | 3.004M |
September 30, 2014 | 3.059M |
June 30, 2014 | 1.966M |
March 31, 2014 | 1.553M |
December 31, 2013 | 1.520M |
September 30, 2013 | 1.215M |
June 30, 2013 | 1.365M |
March 31, 2013 | 1.652M |
December 31, 2012 | 1.124M |
September 30, 2012 | 1.024M |
June 30, 2012 | 1.220M |
March 31, 2012 | 1.231M |
December 31, 2011 | 1.304M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.111M
Minimum
Dec 2023
4.518M
Maximum
Mar 2022
2.550M
Average
2.462M
Median
Accounts Payable (Quarterly) Benchmarks
Eagle Pharmaceuticals Inc | 15.84M |
Marinus Pharmaceuticals Inc | 6.125M |
NovaBay Pharmaceuticals Inc | 1.117M |
Palatin Technologies Inc | 3.443M |
iBio Inc | 1.859M |